Literature DB >> 21947748

Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers.

Guzin Gonullu Demirag1, Yurdanur Sullu, Idris Yucel.   

Abstract

UNLABELLED: Plakophilins (PKP) are desmosomal plague proteins, which belong to the p120ctn subfamily of armadillo repeat containing proteins. We aimed to analyze the role of plakophilins in breast cancer and its clinical progress. We have performed immunohistochemical study of the PKP1,2,3 in breast carcinoma. The study included 108 patients with breast cancer and 26 age- and sex-matched healthy controls. We investigated the associations between staining intensity and some clinicopathologic features like tumor size, axillary node status, stage, lymphovascular invasion, perineural invasion, grade, hormone receptor status, and c-erb B2. The mean age of patients was 46 years (22-78). In breast cancer, compared with normal tissue, PKP1 and PKP2 expressions were indifferent (P > 0.05), but PKP3 expression was significantly increased in breast cancer (P = 0.0014). Although PKP1 and PKP2 expression levels were not correlated with clinicopathological parameters, increased PKP3 expression was positively correlated with node positivity and grade (P = 0.000, P = 0.000).
CONCLUSION: Overexpressed PKP3 is likely to be an essential contributor to a growth-promoting pathway and to aggressive features of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947748     DOI: 10.1007/s12032-011-0071-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  22 in total

Review 1.  Plakophilins--hard work in the desmosome, recreation in the nucleus?

Authors:  Ansgar Schmidt; Stephanie Jäger
Journal:  Eur J Cell Biol       Date:  2005-03       Impact factor: 4.492

Review 2.  Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion?

Authors:  Mechthild Hatzfeld
Journal:  Biochim Biophys Acta       Date:  2006-05-06

3.  Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression.

Authors:  Sonja Breuninger; Sonja Reidenbach; Christian Georg Sauer; Philipp Ströbel; Jesco Pfitzenmaier; Lutz Trojan; Ilse Hofmann
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

4.  Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues.

Authors:  C Mertens; C Kuhn; R Moll; I Schwetlick; W W Franke
Journal:  Differentiation       Date:  1999-06       Impact factor: 3.880

5.  Cell type-specific desmosomal plaque proteins of the plakoglobin family: plakophilin 1 (band 6 protein).

Authors:  H W Heid; A Schmidt; R Zimbelmann; S Schäfer; S Winter-Simanowski; S Stumpp; M Keith; U Figge; M Schnölzer; W W Franke
Journal:  Differentiation       Date:  1994-12       Impact factor: 3.880

6.  Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters.

Authors:  Silvana Papagerakis; Al-Hassan Shabana; Joël Depondt; Pierre Gehanno; Nadine Forest
Journal:  Hum Pathol       Date:  2003-06       Impact factor: 3.466

7.  Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis.

Authors:  Samrat T Kundu; Prajakta Gosavi; Nileema Khapare; Rachana Patel; Amol S Hosing; Girish B Maru; Arvind Ingle; James A Decaprio; Sorab N Dalal
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

8.  Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.

Authors:  Irene Y Cheung; Yi Feng; Karen Danis; Neerav Shukla; Paul Meyers; Marc Ladanyi; Nai-Kong V Cheung
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

9.  Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells.

Authors:  S Bonné; J van Hengel; F Nollet; P Kools; F van Roy
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

10.  The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.

Authors:  Kirsten Aigner; Luise Descovich; Mario Mikula; Aneesa Sultan; Brigitta Dampier; Stefan Bonné; Frans van Roy; Wolfgang Mikulits; Martin Schreiber; Thomas Brabletz; Wolfgang Sommergruber; Norbert Schweifer; Andreas Wernitznig; Hartmut Beug; Roland Foisner; Andreas Eger
Journal:  FEBS Lett       Date:  2007-03-21       Impact factor: 4.124

View more
  12 in total

1.  Plakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis.

Authors:  Cheng Yang; Philipp Ströbel; Alexander Marx; Ilse Hofmann
Journal:  Virchows Arch       Date:  2013-07-24       Impact factor: 4.064

2.  Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.

Authors:  Cheng Yang; Regina Fischer-Kešo; Tanja Schlechter; Philipp Ströbel; Alexander Marx; Ilse Hofmann
Journal:  Tumour Biol       Date:  2015-07-04

3.  Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner.

Authors:  Hope E Burks; Christopher R Arnette; Alejandra Valenzuela-Iglesias; Amulya Yalamanchili; Oxana Nekrasova; Lisa M Godsel; Kathleen J Green
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

Review 4.  Desmosome regulation and signaling in disease.

Authors:  Joshua A Broussard; Spiro Getsios; Kathleen J Green
Journal:  Cell Tissue Res       Date:  2015-02-19       Impact factor: 5.249

Review 5.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

6.  N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.

Authors:  Zhenchuan Liu; Tingting Wang; Yunlang She; Kaiqing Wu; Shaorui Gu; Lei Li; Chenglai Dong; Chang Chen; Yongxin Zhou
Journal:  Mol Cancer       Date:  2021-08-20       Impact factor: 27.401

7.  Plakophilin-3 is required for late embryonic amphibian development, exhibiting roles in ectodermal and neural tissues.

Authors:  William A Munoz; Malgorzata Kloc; Kyucheol Cho; Moonsup Lee; Ilse Hofmann; Amy Sater; Kris Vleminckx; Pierre D McCrea
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

8.  Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.

Authors:  Elise P Salerno; Davide Bedognetti; Ileana S Mauldin; Donna H Deacon; Sofia M Shea; Joel Pinczewski; Joseph M Obeid; George Coukos; Ena Wang; Thomas F Gajewski; Francesco M Marincola; Craig L Slingluff
Journal:  Oncoimmunology       Date:  2016-10-18       Impact factor: 8.110

9.  Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.

Authors:  Hua Qian; Donglan Yuan; Jingjing Bao; Fuxing Liu; Wenyan Zhang; Xumei Yang; Gaohua Han; Junxing Huang; Haihui Sheng; Hong Yu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

10.  Plakophilin-3 catenin associates with the ETV1/ER81 transcription factor to positively modulate gene activity.

Authors:  William A Munoz; Moonsup Lee; Rachel K Miller; Zamal Ahmed; Hong Ji; Todd M Link; Gilbert R Lee; Malgorzata Kloc; John E Ladbury; Pierre D McCrea
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.